Clinical Trial: A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase 1 Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects A Single Centre, Ra

Brief Summary: The objective of the trial is to investigate skin irritation, phototoxicity and safety of LEO 90105 and its components by patchtest (48 hours closed patch test and photo patch test) in healthy Japanese male subjects.

Detailed Summary:
Sponsor: LEO Pharma

Current Primary Outcome: Skin irritation [ Time Frame: 5 days ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: LEO Pharma

Dates:
Date Received: February 9, 2011
Date Started: December 2010
Date Completion:
Last Updated: March 25, 2015
Last Verified: March 2015